Chandan Healthcare IPO

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services. As of December 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 23 cities across Uttar Pradesh and over 19 in Uttarakhand. As of December 31, 2024, the company offers 1,496 tests across different specialities. The test menu includes 481 routine pathology tests in basic biochemistry and haematology, plus 1,015 specialised tests like immunohistopathology and molecular pathology, and 545 radiology tests, including x-rays, ultrasonography, CT, MRI, and specialised CT scans. The radiology facilities have eleven CT scanners and four MRI machines. As of December 31, 2024, the company employed 15 radiologists, 23 pathologists, and over 161 other qualified professionals. Products and services: The company primarily provides diagnostic services and ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products. Routine Pathology Tests Specialized Pathology Tests Radiology Tests Preventive and Wellness Services Home Collection Service Competitive Strength: Strong geographic presence in Uttarakhand, including 39 tier-two cities and towns. Integrated diagnostics provider offering pathology, radiology testing, and medical consultations. Track record of profitability and consistent financial performance. Dedicated management team with significant industry experience.

The company proposes to utilize the Net Proceeds from the Offer towards the following objects: Setting up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh. Setting up a new Central Reference laboratory at Ayodhya, Uttar Pradesh Setting up a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh. General corporate purposes.

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App